Pharmaceutical companies have stepped up pressure on the Government to push back against proposed new regulations of the ...

Marina Hickson, Chief Executive Officer, VivantiIn the fast-paced pharmaceutical industry, sales teams face increasing ...

With Trumps tariffs poised to disrupt global pharma trade, industry stakeholders see opportunities for India, provided it ...

Long a lobbying powerhouse in Washington, pharma’s struggling to settle on a strategy for defending itself, according to six industry lobbyists and three company officials who spoke to POLITICO. All ...

European drugmakers are urging the EU to allow higher medicine prices, warning that without stronger investment incentives, ...

Big Pharma, long a lobbying powerhouse in Washington, is struggling to settle on a strategy for defending itself against ...

Aurobindo Pharma's Eugia Pharma approved to manufacture Dasatinib Tablets, a bioequivalent to Bristol-Myers Squibb's Sprycel, ...

Big Pharma's M&A plans will likely take a hit if the U.S. government under the Trump administration lives up to its threats ...

Big Pharma continues fighting nationwide to block access to a vital drug program ― including here in Oklahoma.

The European Commission has no plans to withdraw or revise its proposed overhaul of EU pharmaceutical rules, despite mounting ...

Amidst the voluminous commentaries, blogs, tweets, panels and papers about the future of the pharma industry, in some circles certain thoughts seem to be becoming articles of faith: 1 ...

Pharmaceutical companies in Europe are requesting the EU to adopt drug pricing strategies comparable to the US.